- directed: true
  graph:
    disease: Acne vulgaris
    disease_mesh: MESH:D000152
    drug: drospirenone
    drug_mesh: MESH:C035144
    drugbank: DB:DB01395
  links:
    - key: negatively regulates
      source: MESH:C035144
      target: UniProt:P10275
    - key: positively regulates
      source: UniProt:P10275
      target: GO:0006702
    - key: positively regulates
      source: MESH:C035144
      target: UniProt:P06401
    - key: negatively correlated with
      source: UniProt:P06401
      target: GO:0006702
    - key: increases abundance of
      source: GO:0006702
      target: UBERON:0001866
    - key: produced by
      source: UBERON:0001866
      target: HP:0025249
    - key: positively correlated with
      source: HP:0025249
      target: MESH:D000152
  multigraph: true
  nodes:
    - id: MESH:C035144
      label: Drug
      name: drospirenone
    - id: UniProt:P06401
      label: Protein
      name: Progesterone receptor
    - id: UniProt:P10275
      label: Protein
      name: Androgen receptor
    - id: GO:0006702
      label: BiologicalProcess
      name: androgen biosynthetic process
    - id: UBERON:0001866
      label: GrossAnatomicalStructure
      name: sebum
    - id: HP:0025249
      label: PhenotypicFeature
      name: Comedo
    - id: MESH:D000152
      label: Disease
      name: Acne vulgaris
  reference: https://go.drugbank.com/drugs/DB01395#mechanism-of-action
  comments: Drospirenone seems to have much lower affinity to androgen receptor than to the progesterone counterpart (https://en.wikipedia.org/wiki/Drospirenone#Pharmacology).
- directed: true
  graph:
    disease: Premenstrual dysphoric disorder
    disease_mesh: MESH:D065446
    drug: drospirenone
    drug_mesh: MESH:C035144
    drugbank: DB:DB01395
  links:
    - key: negatively regulates
      source: MESH:C035144
      target: UniProt:P08235
    - key: positively correlated with
      source: UniProt:P08235
      target: GO:0005890
    - key: positively correlated with
      source: UniProt:P08235
      target: MESH:D015222
    - key: regulates
      source: GO:0005890
      target: GO:0070294
    - key: regulates
      source: GO:0005890
      target: GO:0036359
    - key: regulates
      source: MESH:D015222
      target: GO:0070294
    - key: correlated with
      source: GO:0036359
      target: HP:0000969
    - key: correlated with
      source: GO:0070294
      target: HP:0000969
    - key: correlated with
      source: GO:0036359
      target: MESH:D059373
    - key: correlated with
      source: GO:0070294
      target: MESH:D059373
    - key: manifestation of
      source: MESH:D059373
      target: MESH:D065446
    - key: correlated with
      source: HP:0000969
      target: MESH:D065446
  multigraph: true
  nodes:
    - id: MESH:C035144
      label: Drug
      name: drospirenone
    - id: UniProt:P08235
      label: Protein
      name: Mineralocorticoid receptor
    - id: MESH:D015222
      label: GeneFamily
      name: Sodium Channels
    - id: GO:0005890
      label: CellularComponent
      name: sodium:potassium-exchanging ATPase complex
    - id: GO:0070294
      label: BiologicalProcess
      name: renal sodium ion absorption
    - id: GO:0036359
      label: BiologicalProcess
      name: renal potassium excretion
    - id: HP:0000969
      label: PhenotypicFeature
      name: Edema
    - id: MESH:D059373
      label: PhenotypicFeature
      name: Mastodynia
    - id: MESH:D065446
      label: Disease
      name: Premenstrual dysphoric disorder
  reference: https://go.drugbank.com/drugs/DB01395#mechanism-of-action https://en.wikipedia.org/wiki/Antimineralocorticoid#Mechanism_of_action https://pubmed.ncbi.nlm.nih.gov/18472980/
  comments: The use of progesterone, progestin and similar compounds may not be superior to placebo in reducing premenstrual symptoms judging from the results of the majority of controlled trials (https://pubmed.ncbi.nlm.nih.gov/7791258/). Also note that it is generally agreed that neither a deficiency nor excess in progesterone/progestin levels is etiologically relevant to the disorder (https://pubmed.ncbi.nlm.nih.gov/16650465/). It's largelly accepted that SSRIs as better treatment and should be the first attempt for treatment of premenstrual dysphoric disorder.
- directed: true
  graph:
    disease: Hot Flashes
    disease_mesh: MESH:D019584
    drug: drospirenone
    drug_mesh: MESH:C035144
    drugbank: DB:DB01395
  links:
    - key: positively regulates
      source: MESH:C035144
      target: UniProt:P06401
    - key: decreases abundance of
      source: UniProt:P06401
      target: Pfam:PF00446
    - key: positively correlated with
      source: Pfam:PF00446
      target: MESH:D019584
    - key: correlated with
      source: UniProt:P06401
      target: MESH:D014666
    - key: positively regulates
      source: MESH:D014666
      target: GO:0001659
    - key: negatively correlated with
      source: GO:0001659
      target: HP:0005968
    - key: positively correlated with
      source: HP:0005968
      target: MESH:D019584
  multigraph: true
  nodes:
    - id: MESH:C035144
      label: Drug
      name: drospirenone
    - id: UniProt:P06401
      label: Protein
      name: Progesterone receptor
    - id: Pfam:PF00446
      label: GeneFamily
      name: Gonadotropin-releasing hormone
    - id: MESH:D014666
      label: GrossAnatomicalStructure
      name: Vasomotor System
    - id: GO:0001659
      label: BiologicalProcess
      name: temperature homeostasis
    - id: HP:0005968
      label: PhenotypicFeature
      name: Temperature instability
    - id: MESH:D019584
      label: Disease
      name: Hot Flashes
  reference: https://go.drugbank.com/drugs/DB01395#mechanism-of-action https://en.wikipedia.org/wiki/Progestogen_(medication)#Pharmacodynamics https://www.tandfonline.com/doi/full/10.1080/13697137.2018.1472567 https://journals.lww.com/co-endocrinology/Abstract/2015/12000/Progesterone_or_progestin_as_menopausal_ovarian.13.aspx
  comments: The disease is denoted Menopausal flushing in the original file. Note that a combination therapy of estradiol and drospirenone would be more effective at reducing the frequency of hot flushes and other menopausal symptoms, than a mono-therapy relying on progestin only. Also, since many progestogens have off-target effects including estrogenic effects, the improvement in hot flashes maybe due to the drug binding to estrogen receptors instead. Note the term Vasomotor System (https://en.wikipedia.org/wiki/Vasomotor_center) does not seem to be represented in other ontologies.
- directed: true
  graph:
    disease: Atrophic vaginitis
    disease_mesh: MESH:D059268
    drug: drospirenone
    drug_mesh: MESH:C035144
    drugbank: DB:DB01395
  links:
    - key: positively regulates
      source: MESH:C035144
      target: UniProt:P06401
    - key: participates in
      source: UniProt:P06401
      target: REACT:R-HSA-9018519
    - key: negatively correlated with
      source: REACT:R-HSA-9018519
      target: HP:0031088
    - key: negatively correlated with
      source: REACT:R-HSA-9018519
      target: HP:0030683
    - key: manifestation of
      source: HP:0030683
      target: MESH:D059268
    - key: manifestation of
      source: HP:0031088
      target: MESH:D059268
  multigraph: true
  nodes:
    - id: MESH:C035144
      label: Drug
      name: drospirenone
    - id: UniProt:P06401
      label: Protein
      name: Progesterone receptor
    - id: REACT:R-HSA-9018519
      label: Pathway
      name: Estrogen-dependent gene expression
    - id: HP:0030683
      label: PhenotypicFeature
      name: Vaginitis
    - id: HP:0031088
      label: PhenotypicFeature
      name: Vaginal dryness
    - id: MESH:D059268
      label: Disease
      name: Atrophic vaginitis
  reference: https://go.drugbank.com/drugs/DB01395#mechanism-of-action https://en.wikipedia.org/wiki/Antimineralocorticoid#Mechanism_of_action https://pubmed.ncbi.nlm.nih.gov/18472980/
  comments: Note that the combination therapy of estradiol and drospirenone would be more effective at treating atrophic vaginitis, than a mono-therapy relying on progestin only. Also, since many progestogens have off-target effects including estrogenic effects, the improvement in hot flashes maybe due to the drug binding to estrogen receptors instead.
- directed: true
  graph:
    disease: Diarrhea
    disease_mesh: MESH:D003967
    drug: morphine
    drug_mesh: MESH:D009020
    drugbank: DB:DB00295
  links:
    - key: positively regulates
      source: MESH:D009020
      target: InterPro:IPR001418
    - key: increases abundance of
      source: InterPro:IPR001418
      target: CHEBI:16480
    - key: negatively regulates
      source: CHEBI:16480
      target: GO:0120054
    - key: decreases activity of
      source: InterPro:IPR001418
      target: GO:0035483
    - key: decreases activity of
      source: InterPro:IPR001418
      target: GO:0030432
    - key: increases activity of
      source: GO:0035483
      target: GO:0120054
    - key: increases activity of
      source: GO:0030432
      target: GO:0120054
    - key: negatively correlated with
      source: GO:0120054
      target: HP:0002019
    - key: negatively correlated with
      source: HP:0002019
      target: MESH:D003967
  multigraph: true
  nodes:
    - id: MESH:D009020
      label: Drug
      name: morphine
    - id: InterPro:IPR001418
      label: GeneFamily
      name: Opioid receptor
    - id: GO:0030432
      label: BiologicalProcess
      name: peristalsis
    - id: GO:0035483
      label: BiologicalProcess
      name: gastric emptying
    - id: CHEBI:16480
      label: ChemicalSubstance
      name: nitric oxide
    - id: GO:0120054
      label: BiologicalProcess
      name: intestinal motility
    - id: HP:0002019
      label: PhenotypicFeature
      name: Constipation
    - id: MESH:D003967
      label: Disease
      name: Diarrhea
  reference: https://go.drugbank.com/drugs/DB00295#mechanism-of-action https://en.wikipedia.org/wiki/Analgesic#Opioids https://en.wikipedia.org/wiki/Morphine#Constipation
- directed: true
  graph:
    disease: Pain
    disease_mesh: MESH:D010146
    drug: morphine
    drug_mesh: MESH:D009020
    drugbank: DB:DB00295
  links:
    - key: increases activity of
      source: MESH:D009020
      target: InterPro:IPR001418
    - key: decreases activity of
      source: InterPro:IPR001418
      target: GO:0019233
    - key: regulates
      source: GO:0019233
      target: MESH:D010146
  multigraph: true
  nodes:
    - id: MESH:D009020
      label: Drug
      name: morphine
    - id: InterPro:IPR001418
      label: GeneFamily
      name: Opioid receptor
    - id: GO:0019233
      label: BiologicalProcess
      name: sensory perception of pain
    - id: MESH:D010146
      label: Disease
      name: Pain
  reference: https://go.drugbank.com/drugs/DB00295#mechanism-of-action https://en.wikipedia.org/wiki/Analgesic#Opioids
- directed: true
  graph:
    disease: Chronic pain
    disease_mesh: MESH:D059350
    drug: morphine
    drug_mesh: MESH:D009020
    drugbank: DB:DB00295
  links:
    - key: increases activity of
      source: MESH:D009020
      target: InterPro:IPR001418
    - key: decreases activity of
      source: InterPro:IPR001418
      target: GO:0019233
    - key: regulates
      source: GO:0019233
      target: MESH:D059350
  multigraph: true
  nodes:
    - id: MESH:D009020
      label: Drug
      name: morphine
    - id: InterPro:IPR001418
      label: GeneFamily
      name: Opioid receptor
    - id: GO:0019233
      label: BiologicalProcess
      name: sensory perception of pain
    - id: MESH:D059350
      label: Disease
      name: Chronic pain
  reference: https://go.drugbank.com/drugs/DB00295#mechanism-of-action https://en.wikipedia.org/wiki/Analgesic#Opioids https://en.wikipedia.org/wiki/Chronic_pain#Opioids
- directed: true
  graph:
    disease: Humoral Hypercalcemia Of Malignancy
    disease_mesh: MESH:C562390
    drug: etidronic acid
    drug_mesh: MESH:D012968
    drugbank: DB:DB01077
  links:
    - key: negatively correlated with
      source: MESH:D012968
      target: GO:0140603
    - key: increases activity of
      source: GO:0140603
      target: CL:0000092
    - key: negatively regulates
      source: MESH:D012968
      target: UniProt:P38606
    - key: positively regulates
      source: UniProt:P38606
      target: GO:1902600
    - key: positively correlated with
      source: GO:1902600
      target: GO:0045453
    - key: positively regulates
      source: MESH:D012968
      target: GO:0006915
    - key: decreases abundance of
      source: GO:0006915
      target: CL:0000092
    - key: positively regulates
      source: CL:0000092
      target: GO:0045453
    - key: positively correlated with
      source: GO:0045453
      target: MESH:C562390
    - key: molecularly interacts with
      source: MESH:D012968
      target: CHEBI:52255
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:0001503
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:1990523
    - key: negatively correlated with
      source: GO:1990523
      target: MESH:C562390
    - key: negatively correlated with
      source: GO:0001503
      target: MESH:C562390
  multigraph: true
  nodes:
    - id: MESH:D012968
      label: Drug
      name: etidronic acid
    - id: GO:0140603
      label: MolecularActivity
      name: ATP hydrolysis activity
    - id: UniProt:P38606
      label: Protein
      name: V-type proton ATPase catalytic subunit A
    - id: GO:1902600
      label: BiologicalProcess
      name: proton transmembrane transport
    - id: CHEBI:52255
      label: ChemicalSubstance
      name: hydroxylapatite
    - id: CL:0000092
      label: Cell
      name: osteoclast
    - id: GO:0045453
      label: BiologicalProcess
      name: bone resorption
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: GO:1990523
      label: BiologicalProcess
      name: bone regeneration
    - id: MESH:C562390
      label: Disease
      name: Humoral Hypercalcemia Of Malignancy
  reference: https://go.drugbank.com/drugs/DB01077#mechanism-of-action https://drugs.ncats.io/drug/M2F465ROXU https://www.caymanchem.com/product/20769/etidronate-(sodium-salt) https://en.wikipedia.org/wiki/Etidronic_acid#Medical
  comments: Etidronate is a weak inhibitor of proton transport in animal models (https://pubmed.ncbi.nlm.nih.gov/8889850/).
- directed: true
  graph:
    disease: Osteitis deformans
    disease_mesh: MESH:D010001
    drug: etidronic acid
    drug_mesh: MESH:D012968
    drugbank: DB:DB01077
  links:
    - key: negatively correlated with
      source: MESH:D012968
      target: GO:0140603
    - key: increases activity of
      source: GO:0140603
      target: CL:0000092
    - key: negatively regulates
      source: MESH:D012968
      target: UniProt:P38606
    - key: positively regulates
      source: UniProt:P38606
      target: GO:1902600
    - key: positively correlated with
      source: GO:1902600
      target: GO:0045453
    - key: positively regulates
      source: MESH:D012968
      target: GO:0006915
    - key: decreases abundance of
      source: GO:0006915
      target: CL:0000092
    - key: positively regulates
      source: CL:0000092
      target: GO:0045453
    - key: positively correlated with
      source: GO:0045453
      target: MESH:D010001
    - key: molecularly interacts with
      source: MESH:D012968
      target: CHEBI:52255
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:0001503
    - key: positively correlated with
      source: CHEBI:52255
      target: GO:1990523
    - key: negatively correlated with
      source: GO:1990523
      target: MESH:D010001
    - key: negatively correlated with
      source: GO:0001503
      target: MESH:D010001
  multigraph: true
  nodes:
    - id: MESH:D012968
      label: Drug
      name: etidronic acid
    - id: GO:0140603
      label: MolecularActivity
      name: ATP hydrolysis activity
    - id: UniProt:P38606
      label: Protein
      name: V-type proton ATPase catalytic subunit A
    - id: GO:1902600
      label: BiologicalProcess
      name: proton transmembrane transport
    - id: CHEBI:52255
      label: ChemicalSubstance
      name: hydroxylapatite
    - id: CL:0000092
      label: Cell
      name: osteoclast
    - id: GO:0045453
      label: BiologicalProcess
      name: bone resorption
    - id: GO:0006915
      label: BiologicalProcess
      name: apoptotic process
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: GO:1990523
      label: BiologicalProcess
      name: bone regeneration
    - id: MESH:D010001
      label: Disease
      name: Osteitis deformans
  reference: https://go.drugbank.com/drugs/DB01077#mechanism-of-action https://drugs.ncats.io/drug/M2F465ROXU https://www.caymanchem.com/product/20769/etidronate-(sodium-salt) https://en.wikipedia.org/wiki/Etidronic_acid#Medical
  comments: Etidronate is a weak inhibitor of proton transport in animal models (https://pubmed.ncbi.nlm.nih.gov/8889850/).
- directed: true
  graph:
    disease: Heterotopic ossification
    disease_mesh: MESH:D009999
    drug: etidronic acid
    drug_mesh: MESH:D012968
    drugbank: DB:DB01077
  links:
    - key: prevents
      source: MESH:D012968
      target: GO:0001503
    - key: correlated with
      source: GO:0001503
      target: HP:0011849
    - key: manifestation of
      source: HP:0011849
      target: MESH:D009999
  multigraph: true
  nodes:
    - id: MESH:D012968
      label: Drug
      name: etidronic acid
    - id: GO:0001503
      label: BiologicalProcess
      name: ossification
    - id: HP:0011849
      label: PhenotypicFeature
      name: Abnormal bone ossification
    - id: MESH:D009999
      label: Disease
      name: Heterotopic ossification
  reference: https://en.wikipedia.org/wiki/Etidronic_acid#Medical
- directed: true
  graph:
    disease: Edema
    disease_mesh: MESH:D004487
    drug: triamterene
    drug_mesh: MESH:D014223
    drugbank: DB:DB00384
  links:
    - key: negatively regulates
      source: MESH:D014223
      target: Pfam:PF00858
    - key: positively regulates
      source: Pfam:PF00858
      target: GO:0070294
    - key: positively correlated with
      source: GO:0070294
      target: GO:0003092
    - key: positively correlated with
      source: GO:0003092
      target: MESH:D004487
  multigraph: true
  nodes:
    - id: MESH:D014223
      label: Drug
      name: triamterene
    - id: Pfam:PF00858
      label: GeneFamily
      name: Amiloride-sensitive sodium channel
    - id: GO:0070294
      label: BiologicalProcess
      name: renal sodium ion absorption
    - id: GO:0003092
      label: BiologicalProcess
      name: renal water retention
    - id: MESH:D004487
      label: Disease
      name: Edema
  reference: https://en.wikipedia.org/wiki/Triamterene#Mechanism_of_action https://go.drugbank.com/drugs/DB00384
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: triamterene
    drug_mesh: MESH:D014223
    drugbank: DB:DB00384
  links:
    - key: negatively regulates
      source: MESH:D014223
      target: Pfam:PF00858
    - key: positively regulates
      source: Pfam:PF00858
      target: GO:0070294
    - key: positively correlated with
      source: GO:0070294
      target: GO:0003092
    - key: positively correlated with
      source: GO:0003092
      target: HP:0011105
    - key: positively correlated with
      source: HP:0011105
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D014223
      label: Drug
      name: triamterene
    - id: Pfam:PF00858
      label: GeneFamily
      name: Amiloride-sensitive sodium channel
    - id: GO:0070294
      label: BiologicalProcess
      name: renal sodium ion absorption
    - id: GO:0003092
      label: BiologicalProcess
      name: renal water retention
    - id: HP:0011105
      label: PhenotypicFeature
      name: Hypervolemia
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://en.wikipedia.org/wiki/Triamterene#Mechanism_of_action https://go.drugbank.com/drugs/DB00384 https://pubmed.ncbi.nlm.nih.gov/25616035/ https://www.heighpubs.org/hjch/ach-aid1011.php
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: labetalol
    drug_mesh: MESH:D007741
    drugbank: DB:DB00598
  links:
    - key: negatively regulates
      source: MESH:D007741
      target: UniProt:P08588
    - key: negatively regulates
      source: MESH:D007741
      target: UniProt:P07550
    - key: negatively regulates
      source: MESH:D007741
      target: UniProt:P35348
    - key: negatively regulates
      source: MESH:D007741
      target: UniProt:P35368
    - key: negatively regulates
      source: MESH:D007741
      target: UniProt:P25100
    - key: participates in
      source: UniProt:P08588
      target: REACT:R-HSA-418555
    - key: participates in
      source: UniProt:P07550
      target: REACT:R-HSA-418555
    - key: participates in
      source: UniProt:P35348
      target: REACT:R-HSA-416476
    - key: participates in
      source: UniProt:P35368
      target: REACT:R-HSA-416476
    - key: participates in
      source: UniProt:P25100
      target: REACT:R-HSA-416476
    - key: positively correlated with
      source: REACT:R-HSA-418555
      target: GO:0060047
    - key: positively correlated with
      source: REACT:R-HSA-416476
      target: GO:0042310
    - key: positively correlated with
      source: GO:0060047
      target: HP:0032263
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D007741
      label: Drug
      name: labetalol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: UniProt:P07550
      label: Protein
      name: Beta-2 adrenergic receptor
    - id: UniProt:P35348
      label: Protein
      name: Alpha-1A adrenergic receptor
    - id: UniProt:P35368
      label: Protein
      name: Alpha-1B adrenergic receptor
    - id: UniProt:P25100
      label: Protein
      name: Alpha-1D adrenergic receptor
    - id: REACT:R-HSA-418555
      label: Pathway
      name: G alpha (s) signalling events
    - id: REACT:R-HSA-416476
      label: Pathway
      name: G alpha (q) signalling events
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: GO:0060047
      label: BiologicalProcess
      name: heart contraction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB00598
  commments: Antagonism of beta-2-adrenergic receptors may lead to some of the side effects of labetalol (e.g. bronchospasms); however this may be slightly attenuated by alpha-1-adrenergic antagonism (https://pubmed.ncbi.nlm.nih.gov/6354658/).
- directed: true
  graph:
    disease: Alcoholism
    disease_mesh: MESH:D000437
    drug: disulfiram
    drug_mesh: MESH:D004221
    drugbank: DB:DB00822
  links:
    - key: negatively regulates
      source: MESH:D004221
      target: Pfam:PF00171
    - key: positively regulates
      source: Pfam:PF00171
      target: GO:0006069
    - key: decreases abundance of
      source: GO:0006069
      target: CHEBI:15343
    - key: positively correlated with
      source: CHEBI:15343
      target: HP:0002017
    - key: positively correlated with
      source: CHEBI:15343
      target: HP:0002098
    - key: positively correlated with
      source: CHEBI:15343
      target: HP:0001033
    - key: positively correlated with
      source: CHEBI:15343
      target: HP:0002098
    - key: positively correlated with
      source: CHEBI:15343
      target: HP:0002017
    - key: correlated with
      source: HP:0001033
      target: MESH:D000437
    - key: correlated with
      source: HP:0002098
      target: MESH:D000437
    - key: correlated with
      source: HP:0002017
      target: MESH:D000437
  multigraph: true
  nodes:
    - id: MESH:D004221
      label: Drug
      name: disulfiram
    - id: Pfam:PF00171
      label: GeneFamily
      name: Aldehyde dehydrogenase family
    - id: CHEBI:15343
      label: ChemicalSubstance
      name: acetaldehyde
    - id: GO:0006069
      label: BiologicalProcess
      name: ethanol oxidation
    - id: HP:0001033
      label: PhenotypicFeature
      name: Facial flushing after alcohol intake
    - id: HP:0002098
      label: PhenotypicFeature
      name: Respiratory distress
    - id: HP:0002017
      label: PhenotypicFeature
      name: Nausea and vomiting
    - id: MESH:D000437
      label: Disease
      name: Alcoholism
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL964/ https://en.wikipedia.org/wiki/Disulfiram https://en.wikipedia.org/wiki/Acetaldehyde#Aggravating_factors
  comments: Note that this drug is used as a support to the treatment of chronic alcoholism by producing an acute sensitivity to ethanol (as part of an avoidance therapy for alcohol abuse). It's been suggested that disulfiram itself is unlikely responsible for the enzyme inactivation in vivo; several active metabolites of the drug, especially diethylthiomethylcarbamate, inhibits the enzyme in vitro (https://pubchem.ncbi.nlm.nih.gov/compound/3117#section=Mechanism-of-Action).
- directed: true
  graph:
    disease: Multiple sclerosis
    disease_mesh: MESH:D009103
    drug: fampridine
    drug_mesh: MESH:D015761
    drugbank: DB:DB06637
  links:
    - key: negatively regulates
      source: MESH:D015761
      target: InterPro:IPR028325
    - key: negatively regulates
      source: InterPro:IPR028325
      target: GO:0019228
    - key: positively correlated with
      source: GO:0019228
      target: GO:0019226
    - key: positively correlated with
      source: GO:0019228
      target: GO:0019227
    - key: negatively correlated with
      source: GO:0019227
      target: HP:0002355
    - key: negatively correlated with
      source: GO:0019226
      target: HP:0002355
    - key: positively correlated with
      source: HP:0002355
      target: MESH:D009103
  multigraph: true
  nodes:
    - id: MESH:D015761
      label: Drug
      name: fampridine
      alt_name:
        - Dalfampridine
        - 4-Aminopyridine
        - 4-AP
    - id: InterPro:IPR028325
      label: GeneFamily
      name: Voltage-gated potassium channel
    - id: GO:0019228
      label: BiologicalProcess
      name: neuronal action potential
    - id: GO:0019227
      label: BiologicalProcess
      name: neuronal action potential propagation
    - id: GO:0019226
      label: BiologicalProcess
      name: transmission of nerve impulse
    - id: HP:0002355
      label: PhenotypicFeature
      name: Difficulty walking
    - id: MESH:D009103
      label: Disease
      name: Multiple sclerosis
  reference: https://go.drugbank.com/drugs/DB06637 https://en.wikipedia.org/wiki/4-Aminopyridine#Multiple_sclerosis
- directed: true
  graph:
    disease: Testicular Neoplasms
    disease_mesh: MESH:D013736
    drug: plicamycin
    drug_mesh: MESH:D008926
    drugbank: DB:DB06810
  links:
    - key: disrupts
      source: MESH:D008926
      target: GO:0000785
    - key: correlated with
      source: GO:0000785
      target: GO:0032774
    - key: positively correlated with
      source: GO:0032774
      target: GO:0008283
    - key: positively correlated with
      source: GO:0008283
      target: HP:0031377
    - key: positively correlated with
      source: HP:0031377
      target: MESH:D013736
  multigraph: true
  nodes:
    - id: MESH:D008926
      label: Drug
      name: plicamycin
      alt_ids:
        - MESH:C066851
    - id: GO:0000785
      label: CellularComponent
      name: chromatin
    - id: GO:0032774
      label: BiologicalProcess
      name: RNA biosynthetic process
    - id: GO:0008283
      label: BiologicalProcess
      name: cell population proliferation
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: MESH:D013736
      label: Disease
      name: Testicular Neoplasms
  reference: https://go.drugbank.com/drugs/DB06810 https://en.wikipedia.org/wiki/Plicamycin
  comments: The disease is denoted as Malignant tumor of testis in the original file as per DrugCentral.
- directed: true
  graph:
    disease: Tinea Versicolor
    disease_mesh: MESH:D014010
    drug: oxiconazole
    drug_mesh: MESH:C022155
    drugbank: DB:DB00239
  links:
    - key: negatively regulates
      source: MESH:C022155
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: located in
      source: CHEBI:16933
      target: GO:0030445
    - key: in taxon
      source: GO:0030445
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D014010
  multigraph: true
  nodes:
    - id: MESH:C022155
      label: Drug
      name: oxiconazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D014010
      label: Disease
      name: Tinea Versicolor
  reference: https://go.drugbank.com/drugs/DB00239 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacology
  comments: The disease is denoted as Pityriasis versicolor in the original file as per DrugCentral.
- directed: true
  graph:
    disease: Tinea pedis
    disease_mesh: MESH:D014008
    drug: oxiconazole
    drug_mesh: MESH:C022155
    drugbank: DB:DB00239
  links:
    - key: negatively regulates
      source: MESH:C022155
      target: UniProt:P10613
    - key: positively regulates
      source: UniProt:P10613
      target: GO:0006696
    - key: produces
      source: GO:0006696
      target: CHEBI:16933
    - key: located in
      source: CHEBI:16933
      target: GO:0030445
    - key: in taxon
      source: GO:0030445
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D014008
  multigraph: true
  nodes:
    - id: MESH:C022155
      label: Drug
      name: oxiconazole
    - id: UniProt:P10613
      label: Protein
      name: Lanosterol 14-alpha demethylase
    - id: GO:0006696
      label: BiologicalProcess
      name: ergosterol biosynthetic process
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D014008
      label: Disease
      name: Tinea pedis
  reference: https://go.drugbank.com/drugs/DB00239 https://en.wikipedia.org/wiki/Clotrimazole#Pharmacology
- directed: true
  graph:
    disease: Major depressive disorder
    disease_mesh: MESH:D003865
    drug: reboxetine
    drug_mesh: MESH:C074679
    drugbank: DB:DB00234
  links:
    - key: negatively regulates
      source: MESH:C074679
      target: UniProt:P23975
    - key: positively regulates
      source: UniProt:P23975
      target: GO:0051620
    - key: positively correlated with
      source: GO:0051620
      target: MESH:D003865
  multigraph: true
  nodes:
    - id: MESH:C074679
      label: Drug
      name: reboxetine
    - id: UniProt:P23975
      label: Protein
      name: Sodium-dependent noradrenaline transporter
    - id: GO:0051620
      label: BiologicalProcess
      name: norepinephrine uptake
    - id: MESH:D003865
      label: Disease
      name: Major depressive disorder
  reference: https://go.drugbank.com/drugs/DB00234 https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL14370/
  comments: MESH:D003865 is denoted as Depressive Disorder, Major in the MESH website. Note that the drug may slighlty inhibit the reuptake of serotonin too.
- directed: true
  graph:
    disease: Sexual Dysfunctions, Psychological
    disease_mesh: MESH:D020018
    drug: flibanserin
    drug_mesh: MESH:C098107
    drugbank: DB:DB04908
  links:
    - key: positively regulates
      source: MESH:C098107
      target: UniProt:P08908
    - key: positively regulates
      source: UniProt:P08908
      target: GO:0099155
    - key: positively regulates
      source: UniProt:P08908
      target: GO:0014046
    - key: increases abundance of
      source: GO:0014046
      target: CHEBI:18243
    - key: negatively correlated with
      source: CHEBI:18243
      target: HP:0046504
    - key: negatively correlated with
      source: GO:0099155
      target: HP:0046504
    - key: negatively regulates
      source: MESH:C098107
      target: UniProt:P28223
    - key: positively regulates
      source: UniProt:P28223
      target: GO:0099153
    - key: positively correlated with
      source: GO:0099153
      target: HP:0046504
    - key: positively regulates
      source: UniProt:P08908
      target: GO:0014046
    - key: negatively correlated with
      source: CHEBI:18243
      target: HP:0046504
    - key: manifestation of
      source: HP:0046504
      target: MESH:D020018
  multigraph: true
  nodes:
    - id: MESH:C098107
      label: Drug
      name: flibanserin
    - id: UniProt:P08908
      label: Protein
      name: 5-hydroxytryptamine receptor 1A
    - id: UniProt:P28223
      label: Protein
      name: 5-hydroxytryptamine receptor 2A
    - id: GO:0014046
      label: BiologicalProcess
      name: dopamine secretion
    - id: CHEBI:18243
      label: ChemicalSubstance
      name: dopamine
    - id: GO:0099153
      label: BiologicalProcess
      name: synaptic transmission, serotonergic
    - id: GO:0099155
      label: BiologicalProcess
      name: synaptic transmission, noradrenergic
    - id: HP:0046504
      label: PhenotypicFeature
      name: Decreased libido
    - id: MESH:D020018
      label: Disease
      name: Sexual Dysfunctions, Psychological
  reference: https://go.drugbank.com/drugs/DB04908 https://en.wikipedia.org/wiki/Sexual_dysfunction#Females
  comments: The disease is denoted as Lack or loss of sexual desire in the original file as per DrugCentral.

